Prevention of erectile dysfunction in men with COVID-19

Rustambek Boboev

doi:10.47689/2181-3663-vol2-iss4-pp1-5

Rustambek Boboev Senior lecturer, Department of Urology, Faculty of Medicine, Andijan State Medical Institute.

DOI

https://doi.org/10.47689/2181-3663-vol2-iss4-pp1-5

Keywords

coronavirus infection , erectile dysfunction , testosterone , libido , erection , prostate

Abstract

Experience gained in the fight against COVID-19 has highlighted that indicators of a predisposition to a more severe course of the disease include not only advanced age, obesity, hypertension, and diabetes mellitus, but also male gender. Notably, one of the consequences of coronavirus infection is endothelial dysfunction. In this condition, the lining of small blood vessels is compromised, leading to insufficient blood supply to the tissues they serve, resulting in functional loss. Studies indicate that this vascular dysfunction may contribute to the development of impotence in men who have recovered from COVID-19.

References

Sivkov A.V., Koryakin A.V., Sinyagin A.A., Apolikhin O.I., Kaprin A.D. The genitourinary system and COVID-19: some aspects. ExperimentalandClinicalUrology2020;(2):18-23.

Karmazanovsky G.G., Zamyatina K.A. Computed tomography diagnostics and monitoring of the course of viral pneumonia caused by the SARS-CoV-2 virus during the operation of the COVID-19 Hospital at the Federal Specialized Medical Research Center. // Medical Visualization 2020; 24(2): 11-36

Bendayan M., Robin G., Hamdi S., Mieusset R., Boitrelle F. COVID-19 in men: With or without virus in semen, spermatogenesis may be impaired// Andrologia2021; 53(1), 226

Çayan S., Uğuz M., Saylam B., Akbay E. Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 (COVID-19) in SARS-CoV-2 infected male patients: a cohort study. // Aging Male 2020; 23(5):1493-1503.

Dutta S., SenguptaP. SARS-CoV-2 and male infertility: possible multifaceted pathology// Reprodsci2021; 28(1): 23–26.

Hackett G., Kirby M. Testosterone deficiency in men infected with COVID-19. //Trends Urology Health, 2020; 11:7-10.

Pozzilli P, Lenzi A. Testosterone, a key hormone in the context of COVID-19 pandemic // Metabolism 2020; 108:152-156.

Rastrelli G. et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients// Andrology 2021; 9(1):88–98.

Salonia A., Corona G., Giwercman A. et al. SARS-CoV-2, testosterone and frailty in males (PROTEGGIMI): a multidimensional research project // Andrology ,2021; 9(1):19-22.

Sansone A., Mollaioli D. et al. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak //J Endocrinol Invest 2021; 44(2): 223–31.

Schroeder M., Tuku B., Jarczak D. The majority of male patients with COVID-19 present low testosterone levels on admission to intensive care in Hamburg, Germany: a retrospective cohort study// Andrology 2021; 9(1):118–124.

Selvaraj K. et al. Testicular Atrophy and Hypothalamic Pathology in COVID-19: possibility of the incidence of male infertility and HPG axis abnormalities// Reprodsci2021; Jan 7,1-8 .

Younis JS, Abassi Z., Skorecki K. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection// J.Physiol Endocrinol metab. 20 20; 318(6): 878-880.

Downloads

60 9

Published

2023-08-25

How to Cite

Boboev, R. 2023. Prevention of erectile dysfunction in men with COVID-19. Preventive Medicine and Health. 2, 4 (Aug. 2023), 1–5. DOI:https://doi.org/10.47689/2181-3663-vol2-iss4-pp1-5.